Results 231 to 240 of about 1,302,226 (351)
Objective The objective of this study was to investigate the relationships among subthalamic nucleus (STN) activity, gait initiation (GI), and freezing of gait (FOG) in patients with Parkinson's disease (PD). Methods We recorded GI and STN local field potentials (LFPs) via externalized cables in 38 patients with PD (35 reporting FOG in daily life ...
Antoine Collomb‐Clerc+12 more
wiley +1 more source
Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies. [PDF]
Ancidoni A+31 more
europepmc +1 more source
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
S. Seshadri+7 more
semanticscholar +1 more source
Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy
Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam+29 more
wiley +1 more source
Facilitators and barriers to codesigning social robots with older adults living with dementia: A scoping review. [PDF]
Hung L+6 more
europepmc +1 more source
Objective Blood‐based biomarkers for Alzheimer's disease (AD), representing antemortem indicators of AD pathophysiology, have greatly improved the accuracy of diagnosis. However, these biomarkers may not capture a frequent coincident pathology, such as cerebrovascular disease.
Tamil Iniyan Gunasekaran+12 more
wiley +1 more source
Lipoprotein levels and statin treatment related to dementia and cognitive decline in individuals with type 2 diabetes: an observational analysis from the ADVANCE study. [PDF]
Af Geijerstam P+7 more
europepmc +1 more source